List of Tables
Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Arginine
Table 3. Key Players of Folic Acid
Table 4. Key Players of Vitamin B6 & B12
Table 5. Key Players of Thiamine
Table 6. Key Players of Vitamin D
Table 7. Key Players of Betaine
Table 8. Key Players of Carglumic Acid
Table 9. Global Amino Acid Metabolism Disorder Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Amino Acid Metabolism Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2020-2025)
Table 13. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2026-2031)
Table 15. Amino Acid Metabolism Disorder Drug Market Trends
Table 16. Amino Acid Metabolism Disorder Drug Market Drivers
Table 17. Amino Acid Metabolism Disorder Drug Market Challenges
Table 18. Amino Acid Metabolism Disorder Drug Market Restraints
Table 19. Global Amino Acid Metabolism Disorder Drug Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Amino Acid Metabolism Disorder Drug Market Share by Players (2020-2025)
Table 21. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2024)
Table 22. Ranking of Global Top Amino Acid Metabolism Disorder Drug Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Amino Acid Metabolism Disorder Drug Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Amino Acid Metabolism Disorder Drug, Headquarters and Area Served
Table 25. Global Key Players of Amino Acid Metabolism Disorder Drug, Product and Application
Table 26. Global Key Players of Amino Acid Metabolism Disorder Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2020-2025)
Table 30. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2026-2031)
Table 32. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2020-2025)
Table 34. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2026-2031)
Table 36. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2026-2031) & (US$ Million)
Table 51. GlaxoSmithKline Company Details
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product
Table 54. GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Amino Acid Metabolism Disorder Drug Product
Table 59. Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. AMINO Company Details
Table 62. AMINO Business Overview
Table 63. AMINO Amino Acid Metabolism Disorder Drug Product
Table 64. AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 65. AMINO Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Amino Acid Metabolism Disorder Drug Product
Table 69. Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Recordati Company Details
Table 72. Recordati Business Overview
Table 73. Recordati Amino Acid Metabolism Disorder Drug Product
Table 74. Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 75. Recordati Recent Development
Table 76. DSM Company Details
Table 77. DSM Business Overview
Table 78. DSM Amino Acid Metabolism Disorder Drug Product
Table 79. DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 80. DSM Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Amino Acid Metabolism Disorder Drug Product
Table 84. Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Kyowa Hakko Kirin Company Details
Table 87. Kyowa Hakko Kirin Business Overview
Table 88. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product
Table 89. Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 90. Kyowa Hakko Kirin Recent Development
Table 91. BioMarin Company Details
Table 92. BioMarin Business Overview
Table 93. BioMarin Amino Acid Metabolism Disorder Drug Product
Table 94. BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 95. BioMarin Recent Development
Table 96. Swedish Orphan Biovitrum Company Details
Table 97. Swedish Orphan Biovitrum Business Overview
Table 98. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product
Table 99. Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 100. Swedish Orphan Biovitrum Recent Development
Table 101. Shine Star (Hubei) Biological Engineering Company Details
Table 102. Shine Star (Hubei) Biological Engineering Business Overview
Table 103. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product
Table 104. Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2020-2025) & (US$ Million)
Table 105. Shine Star (Hubei) Biological Engineering Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Amino Acid Metabolism Disorder Drug Picture
Figure 2. Global Amino Acid Metabolism Disorder Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Amino Acid Metabolism Disorder Drug Market Share by Type: 2024 VS 2031
Figure 4. Arginine Features
Figure 5. Folic Acid Features
Figure 6. Vitamin B6 & B12 Features
Figure 7. Thiamine Features
Figure 8. Vitamin D Features
Figure 9. Betaine Features
Figure 10. Carglumic Acid Features
Figure 11. Sapropterin Dihydrochloride Features
Figure 12. Others Features
Figure 13. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 14. Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2024 VS 2031
Figure 15. Phenylketonuria Case Studies
Figure 16. Maple Syrup Urine Disease Case Studies
Figure 17. Argininosuccinic Acidemia Case Studies
Figure 18. Citrullinemia Case Studies
Figure 19. Homocystinuria Case Studies
Figure 20. Amino Acid Metabolism Disorder Drug Report Years Considered
Figure 21. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Amino Acid Metabolism Disorder Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2024 VS 2031
Figure 24. Global Amino Acid Metabolism Disorder Drug Market Share by Players in 2024
Figure 25. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Amino Acid Metabolism Disorder Drug Revenue in 2024
Figure 27. North America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2020-2031)
Figure 29. United States Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2020-2031)
Figure 33. Germany Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2020-2031)
Figure 41. China Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2020-2031)
Figure 49. Mexico Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2020-2031)
Figure 53. Turkey Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 58. AMINO Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 60. Recordati Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 61. DSM Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 62. Sanofi Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 63. Kyowa Hakko Kirin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 64. BioMarin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 65. Swedish Orphan Biovitrum Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 66. Shine Star (Hubei) Biological Engineering Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
